Igor A. Kos

Homburg, SL, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Plasmacytic markers as immunotherapeutic targets for primary CD20-negative aggressive B-cell lymphomas.

Plasmacytic markers as immunotherapeutic targets for primary CD20-negative aggressive B-cell lymphomas.

Journal: British journal of haematology

Published: February 18, 2026

Early CAR T-cell therapy in relapsed/refractory large B-cell lymphoma is associated with lower hematotoxicity burden.

Early CAR T-cell therapy in relapsed/refractory large B-cell lymphoma is associated with lower hematotoxicity burden.

Journal: Blood advances

Published: September 15, 2025

Early CAR T-cell therapy in relapsed/refractory large B-cell lymphoma is associated with lower hematotoxicity burden.

Early CAR T-cell therapy in relapsed/refractory large B-cell lymphoma is associated with lower hematotoxicity burden.

Journal: Blood advances

Published: September 15, 2025

Impact of Perforin 1 A91V germ line background in patients with aggressive B-NHL treated with R-CHOP.

Impact of Perforin 1 A91V germ line background in patients with aggressive B-NHL treated with R-CHOP.

Journal: Blood advances

Published: April 21, 2025

Impact of Perforin 1 A91V germline background in patients with aggressive B-NHL treated with R-CHOP.

Impact of Perforin 1 A91V germline background in patients with aggressive B-NHL treated with R-CHOP.

Journal: Blood advances

Published: April 21, 2025

Impact of Perforin 1 A91V germ line background in patients with aggressive B-NHL treated with R-CHOP.

Impact of Perforin 1 A91V germ line background in patients with aggressive B-NHL treated with R-CHOP.

Journal: Blood advances

Published: April 21, 2025

Autoantibodies to IL-1Ra and PGRN in severe COVID-19 are associated with inflammation-induced hyperphosphorylated antigen isoforms.

Autoantibodies to IL-1Ra and PGRN in severe COVID-19 are associated with inflammation-induced hyperphosphorylated antigen isoforms.

Journal: Nature communications

Published: March 13, 2025

Cytomegalovirus-Specific T-Cell-Receptor-like Antibodies Target In Vivo-Infected Human Leukocytes Inducing Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity.

Cytomegalovirus-Specific T-Cell-Receptor-like Antibodies Target In Vivo-Infected Human Leukocytes Inducing Natural Killer Cell-Mediated Antibody-Dependent Cellular Cytotoxicity.

Journal: International journal of molecular sciences

Published: October 19, 2024

A German multicenter real-world analysis of talquetamab in 138 patients with relapsed/refractory multiple myeloma.

A German multicenter real-world analysis of talquetamab in 138 patients with relapsed/refractory multiple myeloma.

Journal: HemaSphere

Published: October 01, 2024

Autoantibody mediated deficiency of IL-36-receptor antagonist in a subset of patients with psoriasis and psoriatic arthritis.

Autoantibody mediated deficiency of IL-36-receptor antagonist in a subset of patients with psoriasis and psoriatic arthritis.

Journal: Immunology letters

Published: June 04, 2024

An inherited genetic variant of the CEP72 gene is associated with the development of vincristine-induced peripheral neuropathy in female patients with aggressive B-cell lymphoma.

An inherited genetic variant of the CEP72 gene is associated with the development of vincristine-induced peripheral neuropathy in female patients with aggressive B-cell lymphoma.

Journal: Annals of hematology

Published: April 20, 2024

Lessons Learned from the COVID-19 Pandemic: Interpreting Vaccination Strategies in a Nationwide Demographic Study.

Lessons Learned from the COVID-19 Pandemic: Interpreting Vaccination Strategies in a Nationwide Demographic Study.

Journal: Vaccines

Published: April 16, 2024

Showing 1-12 of 33

Last Updated: 09/26/2026